1. Home
  2. IPGP vs AKRO Comparison

IPGP vs AKRO Comparison

Compare IPGP & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPGP
  • AKRO
  • Stock Information
  • Founded
  • IPGP 1990
  • AKRO 2017
  • Country
  • IPGP United States
  • AKRO United States
  • Employees
  • IPGP N/A
  • AKRO N/A
  • Industry
  • IPGP Semiconductors
  • AKRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPGP Technology
  • AKRO Health Care
  • Exchange
  • IPGP Nasdaq
  • AKRO Nasdaq
  • Market Cap
  • IPGP 3.2B
  • AKRO 3.7B
  • IPO Year
  • IPGP 2006
  • AKRO 2019
  • Fundamental
  • Price
  • IPGP $85.12
  • AKRO $54.20
  • Analyst Decision
  • IPGP Buy
  • AKRO Buy
  • Analyst Count
  • IPGP 7
  • AKRO 10
  • Target Price
  • IPGP $77.60
  • AKRO $73.56
  • AVG Volume (30 Days)
  • IPGP 206.5K
  • AKRO 4.2M
  • Earning Date
  • IPGP 11-04-2025
  • AKRO 11-07-2025
  • Dividend Yield
  • IPGP N/A
  • AKRO N/A
  • EPS Growth
  • IPGP N/A
  • AKRO N/A
  • EPS
  • IPGP N/A
  • AKRO N/A
  • Revenue
  • IPGP $945,994,000.00
  • AKRO N/A
  • Revenue This Year
  • IPGP $0.28
  • AKRO N/A
  • Revenue Next Year
  • IPGP $7.47
  • AKRO N/A
  • P/E Ratio
  • IPGP N/A
  • AKRO N/A
  • Revenue Growth
  • IPGP N/A
  • AKRO N/A
  • 52 Week Low
  • IPGP $48.59
  • AKRO $21.34
  • 52 Week High
  • IPGP $90.30
  • AKRO $58.40
  • Technical
  • Relative Strength Index (RSI)
  • IPGP 50.55
  • AKRO 70.98
  • Support Level
  • IPGP $84.52
  • AKRO $53.40
  • Resistance Level
  • IPGP $88.30
  • AKRO $54.31
  • Average True Range (ATR)
  • IPGP 2.77
  • AKRO 0.27
  • MACD
  • IPGP -0.30
  • AKRO -0.09
  • Stochastic Oscillator
  • IPGP 52.96
  • AKRO 99.45

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

Share on Social Networks: